| Business Summary |
| A biotechnology company committed to building a top tier biopharmaceutical organization that discovers, develops and commercializes innovative molecular targeted therapies addressing major unmet medical needs in oncology, diabetes and obesity. |
| General Information |
41 Pinelawn Road
Melville, NY 11747
|
| www.osip.com |
| Industry : Drugs |
| Sector: Health Care |
| Employees: 491 |
| CEO: Dr. Colin Goddard, Ph.D. |
| Short Interest |
| Current Month (Mil) |
5.52 |
| Previous Month (Mil) |
5.42 |
| Short Interest Ratio (Days) |
5.90 |
| Management Effectiveness |
| Return on Equity |
11.70 |
| Return on Assets |
6.80 |
| Return on Investments |
7.50 |
| Profitability |
| Gross Margin |
n.a. |
| EBIT Margin |
-48.40 |
| Profit Margin |
19.70 |
Connect with TheStreet